Bivalirudin recalls
The FDA has published 1 recall involving Bivalirudin since 2023. The latest was reported on 19 Jul 2023. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 19 Jul 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why bivalirudin is recalled
Companies
By year
All bivalirudin recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bivalirudin for Injection 250 mg-Dose Vials recalledBivalirudin | Accord Healthcare | Particulate Matter | Nationwide |
Should you stop taking Bivalirudin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.